Kanka Gel
NDC Package 10157-2106-2

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Kanka (benzocaine and zinc chloride) gel is adults and children 2 years of age and older: twist base clockwise to dispense. This formulation utilizes a gel delivery system. Marketed by Blistex Inc, this product is identified by NDC 10157-2106 and is authorized under FDA application M022.

Identification & Billing

NDC Package Code
10157-2106-2
Package Description
2 APPLICATOR in 1 BLISTER PACK / 2 g in 1 APPLICATOR
Product Code
10157-2106
11-Digit Billing Format
10157210602
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Kanka Softbrush
Non-Proprietary Name
Benzocaine And Zinc Chloride
Substance Name
Benzocaine; Zinc Chloride
Dosage Form
Gel - A semisolid3 dosage form that contains a gelling agent to provide stiffness to a solution or a colloidal dispersion.4 A gel may contain suspended particles.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Adults and children 2 years of age and older: twist base clockwise to dispense. It may take up to 10 full turns to dispense the initial dose, but subsequent uses should require less than 1 turn.to clean brush tip, rinse with cold waterdry affected area and apply medication by gently brushing the affected area.use up to 4 times daily, or as directed by a dentist or doctorchildren under 12 years of age should be supervised in the use of this productchildren under 2 years of age: do not use

Regulatory & Marketing

Labeler Name
Blistex Inc
Product Type
Human Otc Drug
FDA Application #
M022
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
09-25-2019
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (10157-2106). Click a package code to view its specific billing and regulatory data.

10157-2106-1
1 APPLICATOR in 1 BLISTER PACK / 2 g in 1 APPLICATOR

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 10157-2106-2 identifies a specific commercial package of 2 applicator in 1 blister pack / 2 g in 1 applicator of Kanka Softbrush, a human over the counter drug labeled by Blistex Inc. This gel is formulated for oral use and contains benzocaine; zinc chloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Blistex Inc on September 25, 2019. The current certification is valid through December 31, 2026.

How is this Blistex Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 10157210602. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
10157-2106-2
11-Digit CMS (5-4-2)
10157-2106-02

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.